Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepatica

Parasitology

Volumn 138, Issue 2, 2011, Pages 224-236

  Devine, C ^a   Brennan, G P ^a   Lanusse, C E ^b   Alvarez, L I ^b   Trudgett, A ^a   Hoey, E ^a   Fairweather, I ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

Author keywords

Fasciola hepatica; liver fluke; piperonyl butoxide; transmission electron microscopy; triclabendazole resistance

Indexed keywords

GLYCOSAMINOGLYCAN; PIPERONYL BUTOXIDE; TRICLABENDAZOLE;

ARTICLE; CELL DISRUPTION; CELL MEMBRANE; CONTROLLED STUDY; DRUG MECHANISM; DRUG METABOLISM; FASCIOLA HEPATICA; GOLGI COMPLEX; MITOCHONDRION; MORPHOLOGY; NONHUMAN; PARASITE ISOLATION; PRIORITY JOURNAL; SYNCYTIUM; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY;

FASCIOLA HEPATICA;

EID: 79951578349     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182010001125     Document Type: Article

References (34)

1. Alvarez, L. I., Solana, H. D., Mottier, M. L., Virkel, G. L., Fairweather, I. and Lanusse, C. E. (2005). Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes. Parasitology 131, 501-510. (Pubitemid 43329682)
2. Benchaoui, H. A. and McKellar, Q. A. (1996). Interaction between fenbendazole and piperonyl butoxide: Pharmacokinetic and pharmacodynamic implications. Journal of Pharmacy and Pharmacology 48, 753-759. (Pubitemid 26283270)
3. Buchanan, J. F., Fairweather, I., Brennan, G. P., Trudgett, A. and Hoey, E. M. (2003). Surface and internal tegumental changes induced by treatment in vitro with the sulphoxide metabolite of albendazole ('Valbazen'). Parasitology 126, 141-153. (Pubitemid 36308250)
4. Devine, C., Brennan, G. P., Lanusse, C. E., Alvarez, L. I., Trudgett, A., Hoey, E. and Fairweather, I. (2009). Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica. Parasitology 136, 183-192.
5. Devine, C., Brennan, G. P., Lanusse, C. E., Alvarez, L. I., Trudgett, A., Hoey, E. and Fairweather, I. (2010a). Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazole. Parasitology 137, 871-880.
6. Devine, C., Brennan, G. P., Lanusse, C. E., Alvarez, L. I., Trudgett, A., Hoey, E. and Fairweather, I. (2010b). Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica. Parasitology Research 106, 1351-1363.
7. Devine, C., Brennan, G. P., Lanusse, C. E., Alvarez, L. I., Trudgett, A., Hoey, E. and Fairweather, I. (2010c). Enhancement of the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica using the metabolic inhibitor ketoconazole. Parasitology Research 107, 337-353.
8. Fairweather, I., Anderson, H. R. and Threadgold, L. T. (1986). Fasciola hepatica: Tegumental changes induced in vitro by the deacetylated (amine) metabolite of diamphenethide. Experimental Parasitology 62, 336-348. (Pubitemid 17202433)
9. Fairweather, I., Threadgold, L. T. and Hanna, R. E. B. (1999). Development of Fasciola hepatica in the mammalian host. In Fasciolosis (ed. Dalton, J. P.), pp. 47-111. CAB International, Wallingford, Oxon, UK.
10. Gottschall, D.W., Theodorides, V. J. and Wang, R. (1990). The metabolism of benzimidazole anthelmintics. Parasitology Today 6, 115-124.
11. Halferty, L., Brennan, G. P., Trudgett, A., Hoey, L. and Fairweather, I. (2009). The relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica. Veterinary Parasitology 159, 126-138.
12. McConville, M., Brennan, G. P., Flanagan, A., Edgar, H.W. J., McCoy, M., Castillo, R., Hernández-Campos, A. and Fairweather, I. (2008). Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha. Veterinary Parasitology 153, 52-64.
13. McConville, M., Brennan, G. P., Flanagan, A., Edgar, H.W. J., Castillo, R., Hernández-Campos, A. and Fairweather, I. (2009). Ultrastructural changes to the tegumental system and the gastrodermal cells in adult Fasciola hepatica following in vivo treatment with the experimental fasciolicide, compound alpha. Parasitology 136, 665-680.
14. McKellar, Q. A., Gokbulut, C., Muzandu, K. and Benchaoui, H. (2002). Fenbendazole pharmacokinetics, metabolism, and potentiation in horses. Drug Metabolism and Disposition 30, 1230-1239. (Pubitemid 35265830)
15. McKinstry, B. D. (2008). Ultrastructural changes observed in Fasciola hepatica following treatment with nitroxynil and triclabendazole, alone and in combination. Ph.D. Thesis, The Queen's University of Belfast, Northern Ireland.
16. McKinstry, B., Fairweather, I., Brennan, G. P. and Forbes, A. B. (2003). Fasciola hepatica: Tegumental surface alterations following treatment in vivo and in vitro with nitroxynil ("Trodax"). Parasitology Research 91, 251-263. (Pubitemid 37260449)
17. McKinstry, B., Brennan, G. P., Halferty, L., Forbes, A. B. and Fairweather, I. (2007). Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax). Parasitology Research 101, 929-941. (Pubitemid 47228799)
18. Meaney, M., Fairweather, I., Brennan, G. P., McDowell, L. S. L. and Forbes, A. B. (2003). Fasciola hepatica: Effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young- and old-mature flukes. Parasitology Research 91, 238-250. (Pubitemid 37260448)
19. Meaney, M., Fairweather, I., Brennan, G. P. and Forbes, A. B. (2004). Transmission electron microscope study of the ultrastructural changes induced in the tegument and gut of Fasciola hepatica following treatment with clorsulon. Parasitology Research 92, 232-241. (Pubitemid 38230476)
20. Meaney, M., Allister, J., McKinstry, B., McLaughlin, K., Brennan, G. P., Forbes, A. B. and Fairweather, I. (2006). Fasciola hepatica: morphological effects of a combination of triclabendazole and clorsulon against mature fluke. Parasitology Research 99, 609-621. (Pubitemid 44337952)
21. Meaney, M., Allister, J., McKinstry, B., McLauglin, K., Brennan, G. P., Forbes, A. B. and Fairweather, I. (2007). Fasciola hepatica: Ultrastructural effects of a combination of triclabendazole and clorsulon against mature fluke. Parasitology Research 100, 1091-1104. (Pubitemid 46354871)
22. Mottier, L., Virkel, G., Solana, H., Alvarez, L., Salles, J. and Lanusse, C. (2004). Triclabendazole biotransformation and comparative diffusion of the parent drug and its oxidized metabolites into Fasciola hepatica. Xenobiotica 34, 1043-1047.
23. Robinson, M.W., Lawson, J., Trudgett, A., Hoey, E. M. and Fairweather, I. (2004). The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica. Parasitology Research 92, 205-210. (Pubitemid 38230471)
24. Rogan, M. T. and Threadgold, L. T. (1984). Fasciola hepatica: Tegumental changes as a result of lectin binding. Experimental Parasitology 57, 248-260. (Pubitemid 14073149)
25. Sanchez, S., Small, J., Jones, D. G. and McKellar, Q. A. (2002). Plasma achiral and chiral pharmacokinetic behavior of intravenous oxfendazole co-administered with piperonyl butoxide in sheep. Journal of Veterinary Pharmacology and Therapeutics 25, 7-13. (Pubitemid 34592070)
26. Sanchez-Bruni, S. F. S., Fusé, L. A., Moreno, L., Saumell, C. A., Álvarez, L. I., Fiel, C., McKellar, Q. A. and Lanusse, C. E. (2005). Changes to oxfendazole chiral kinetics and anthelmintic efficacy induced by piperonyl butoxide in horses. Equine Veterinary Journal 37, 257-262. (Pubitemid 40655935)
27. Skuce, P. J., Anderson, H. R. and Fairweather, I. (1987). The interaction between the deacetylated (amine) metabolite of diamphenethide (DAMD) and cytochemically demonstrable Na+/K+-ATPase activity in the tegument of Fasciola hepatica. Parasitology Research 74, 161-167. (Pubitemid 18014067)
28. Skuce, P. J. and Fairweather, I. (1990). The effect of the hydrogen ionophore closantel upon the pharmacology and ultrastructure of the adult liver fluke Fasciola hepatica. Parasitology Research 76, 241-250. (Pubitemid 20116101)
29. Stitt, A.W. and Fairweather, I. (1993). Fasciola hepatica: Tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex). Parasitology Research 79, 529-536. (Pubitemid 23307173)
30. Stitt, A. and Fairweather, I. (1994). The effect of the sulphoxide metabolite of triclabendazole ('Fasinex') on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica. Parasitology 108, 555-567.
31. Threadgold, L. T. and Brennan, G. P. (1978). Fasciola hepatica: Basal infolds and associated vacuoles of the tegument. Experimental Parasitology 46, 300-316. (Pubitemid 9090546)
32. Velík, J., Baliharová, V., Fink-Gremmels, J., Bull, S., Lamka, J. and Skálová, L. (2004). Benzimidazole drugs and modulation of biotransformation enzymes. Research in Veterinary Science 76, 95-108. (Pubitemid 38258192)
33. Virkel, G., Lifschitz, A., Sallovitz, J., Ballent, M., Scarcella, S. and Lanusse, C. (2009). Inhibition of cytochrome P450 activity enhances the systemic availability of triclabendazole metabolites in sheep. Journal of Veterinary Pharmacology and Therapeutics 32, 79-86.
34. Walker, S. M., McKinstry, B., Boray, J. C., Brennan, G. P., Trudgett, A., Hoey, E. M., Fletcher, H. and Fairweather, I. (2004). Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro. Parasitology Research 94, 427-438. (Pubitemid 40104522)